Invasive fungal infections in patients with hematologic malignancies (Aurora Project): Lights and shadows during 18-months surveillance

International Journal of Molecular Sciences

Volumn 13, Issue 1, 2012, Pages 774-787

  Montagna, Maria Teresa ^a   de Giglio, Osvalda ^a   Napoli, Christian ^a   Lovero, Grazia ^a   Caggiano, Giuseppina ^a   Delia, Mario ^a   Pastore, Domenico ^a   Santoro, Nicola ^b   Specchia, Giorgina ^a  

^a UNIVERSITY OF BARI   (Italy)

^b POLICLINICO   (Italy)

Author keywords

Fungal infections; Onco hematology units; Surveillance

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; CORTICOSTEROID DERIVATIVE; CYCLOSPORIN; CYTARABINE; ENDO 1,3 BETA GLUCANASE; GALACTOMANNAN; IMMUNOSUPPRESSIVE AGENT; SURFACE WATER; BETA GLUCAN; BETA-1,3-D-GLUCAN; MANNAN;

ADOLESCENT; ADULT; AGED; AIR POLLUTION; ALLOGENIC BONE MARROW TRANSPLANTATION; ALTERNARIA ALTERNATA; ANTIBIOTIC THERAPY; ANTIGEN DETECTION; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BLOOD CULTURE; CANCER PATIENT; CANDIDA PARAPSILOSIS; CENTRAL VENOUS CATHETER; CHILD; CONTROLLED STUDY; ENVIRONMENTAL MONITORING; FEMALE; FUNGUS ISOLATION; HEALTH CARE FACILITY; HEALTH SURVEY; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; ITALY; LIGHT; LONGITUDINAL STUDY; LUNG ASPERGILLOSIS; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MULTICENTER STUDY (TOPIC); NEUTROPENIA; PARENTERAL NUTRITION; PROSPECTIVE STUDY; SYSTEMIC MYCOSIS; WATER POLLUTION; ALTERNARIA; BONE MARROW TRANSPLANTATION; CANDIDA; CLINICAL TRIAL; COMPLICATION; HEMATOLOGIC NEOPLASMS; ISOLATION AND PURIFICATION; MIDDLE AGED; MULTICENTER STUDY; MYCOSES; PATHOLOGY; PRESCHOOL CHILD; YOUNG ADULT;

ALTERNARIA ALTERNATA; CANDIDA; CANDIDA PARAPSILOSIS; FUNGI;

ADOLESCENT; ADULT; AGED; ALTERNARIA; ANTINEOPLASTIC AGENTS; BETA-GLUCANS; BONE MARROW TRANSPLANTATION; CANDIDA; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; INCIDENCE; MALE; MANNANS; MIDDLE AGED; MYCOSES; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84856264469     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13010774     Document Type: Article

References (35)

1. Nosari, A.; Oreste, P.; Cairoli, R.; Montillo, M.; Carrafiello, G.; Astolfi, A.; Muti, G.; Marbello, L.; Tedeschi, A.; Magliano, E.; Morra, E. Invasive aspergillosis in hematological malignancies: Clinical findings and management for intensive chemotherapy completion. Am. J. Hematol. 2001, 68, 231-236.
2. Chamilos, G.; Luna, M.; Lewis, R.E.; Bodey, G.P.; Chemaly, R.; Tarrand, J.J.; Safdar, A.; Raad, I.I.; Kontoyiannis, D.P. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: An autopsy study over a 15-year period (1989-2003). Haematologica 2006, 91, 986-989.
3. Pagano, L.; Caira, M.; Nosari, A.; van Lint, M.T.; Candoni, A.; Offidani, M.; Aloisi, T.; Irrera, G.; Bonini, A.; Picardi, M, et al. Fungal infections in recipients of hematopoietic stem cell transplants: Results of the SEIFEM B-2004 study-Sorveglianza Epidemiologica Infezioni Fungine nelle Emopatie Maligne. Clin. Infect. Dis. 2007, 45, 1161-1170.
4. Viscoli, C.; Varnier, O.; Machetti, M. Infections in patients with febrile neutropenia: Epidemiology, microbiology, and risk stratification. Clin. Infect. Dis. 2005, 40, 240-245.
5. Ram, R.; Gafter-Gvili, A.; Raanani, P.; Yeshurun, M.; Shpilberg, O.; Dreyer, J.; Peck, A.; Leibovici, L.; Paul, M. Surveillance of infectious complications in hemato-oncological patients. Isr. Med. Assoc. J. 2009, 11, 133-137.
6. Sainz, J.; Pérez, E.; Hassan, L.; Moratalla, A.; Romero, A.; Collado, M.D.; Jurado, M. Variable number of tandem repeats of TNF receptor type 2 promoter as genetic biomarker of susceptibility to develop invasive pulmonary aspergillosis. Hum. Immunol. 2007, 68, 41-50.
7. Zaas, A.K.; Liao, G.; Chien, J.W.; Weinberg, C.; Shore, D.; Giles, S.S.; Marr, K.A.; Usuka, J.; Burch, L.H.; Perera, L.; Perfect, J.R.; Peltz, G.; Schwartz, D.A. Plasminogen alleles influence susceptibility to invasive aspergillosis. PLoS Genet. 2008, 4, e1000101:1-e1000101:12.
8. Lass-Flörl, C. The changing face of epidemiology of invasive fungal disease in Europe. Mycoses 2009, 52, 197-205.
9. Marr, K.A. Invasive Candida infections: The changing epidemiology. Oncology 2004, 18, 9-14.
10. Girmenia, C.; Pizzarelli, G.; Cristini, F.; Barchiesi, F.; Spreghini, E.; Scalise, G.; Martino, P. Candida guilliermondii fungemia in patients with hematologic malignancies. J. Clin. Microbiol. 2006, 44, 2458-2464.
11. Neofytos, D.; Horn, D.; Anaissie, E.; Steinbach, W.; Olyaei, A.; Fishman, J.; Pfaller, M.; Chang, C.; Webster, K.; Marr, K. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance Registry. Clin. Infect. Dis. 2009, 48, 265-273.
12. Kontoyiannis, D.P.; Lionakis, M.S.; Lewis, R.E.; Chamilos, G.; Healy, M.; Perego, C.; Safdar, A.; Kantarjian, H.; Champlin, R.; Walsh, T.J.; Raad, I.I. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: A case-control observational study of 27 recent cases. J. Infect. Dis. 2005, 191, 1350-1360.
13. Girmenia, C.; Pagano, L.; Martino, B.; D'Antonio, D.; Fanci, R.; Specchia, G.; Melillo, L.; Buelli, M.; Pizzarelli, G.; Venditti, M.; Martino, P. Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: A retrospective multicenter study from Italy and review of the literature. J. Clin. Microbiol. 2005, 43, 1818-1828.
14. Pagano, L.; Caira, M.; Candoni, A.; Offidani, M.; Fianchi, L.; Martino, B.; Pastore, D.; Picardi, M.; Bonini, A.; Chierichini, A, et al. The epidemiology of fungal infections in patients with hematologic malignancies: The SEIFEM-2004 study. Haematologica 2006, 91, 1068-1075.
15. Hsiao, H.H.; Tsai, H.J.; Liu, Y.C.; Tseng, Y.T.; Lu, P.L.; Yang, W.C.; Liu, T.C.; Lin, S.F. Invasive fungal infections in patients with acute leukemia. Kaohsuing J. Med. Sci. 2006, 22, 217-222.
16. Ascioglu, S.; Rex, J.H.; de Pauw, B.; Bennett, J.E.; Bille, J.; Crokaert, F.; Denning, D.W.; Donnelly, J.P.; Edwards, J.E.; Erjavec, Z, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus. Clin. Infect. Dis. 2002, 34, 7-14.
17. Maertens, J.A.; Frere, P.; Lass-Florl, C.; Heinz, W.; Cornely, O.A. Primary antifungal prophylaxis in leukaemia patients. Eur. J. Cancer 2007, 5, 43-48.
18. Walsh, T.J.; Anaissie, E.J.; Denning, D.W.; Herbrecht, R.; Kontoyiannis, D.P.; Marr, K.A.; Morrison, V.A.; Segal, B.H.; Steinbach, W.J.; Stevens, D.A, et al. Treatment of aspergillosis: Clinical practice guidelines of the infectious diseases society of America. Clin. Infect. Dis. 2008, 46, 327-360.
19. de Pauw, B.; Walsh, T.J.; Donnelly, J.P.; Stevens, D.A.; Edwards, J.E.; Calandra, T.; Pappas, P.G.; Maertens, J.; Lortholary, O.; Kauffman, C.A, et al. Revised definitions of invasive fungal diseases from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Disease Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis. 2008, 46, 1813-1821.
20. de Hoog, G.S.; Guarro, J.; Gené, J.; Figueras, M.J. Atlas of Clinical Fungi, 3rd ed.; Centraalbureau voor Schimmelcultures (CBS): Utrecht, The Netherlands, 2009.
21. Department of Health. Specialised Ventilation for Healthcare Premises-Part A: Design and Validation; Health Technical Memorandum 03-01; The Stationery Office: Norwich, UK, 2007.
22. Decreto Legislativo 2 febbraio 2001, n.31: Attuazione della direttiva 98/83/CE relativa alla qualità delle acque destinate al consumo umano. Gazzetta Ufficiale n.52 del 3 marzo 2001-Suppl. Ord.n.41. Available online: http://www.comune.jesi.an.it/MV/gazzette_ufficiali/2001/52/gazzetta52.htm (accessed on 28 Februry 2011)
23. Panagopoulou, P.; Filioti, J.; Petrikkos, G.; Giakouppi, P.; Anatoliotaki, M.; Farmaki, E.; Kanta, A.; Apostolakou, H.; Avlami, A.; Samonis, G.; Roilides, E. Environmental surveillance of filamentous fungi in three tertiary care hospitals in Greece. J. Hosp. Infect. 2002, 52, 185-191.
24. Caggiano, G.; Iatta, R.; Laneve, A.; Manca, F.; Montagna, M.T. Observational study on candidaemia at a university hospital in southern Italy from 1998 to 2004. Mycoses 2008, 51, 123-128.
25. Pfaller, M.A.; Diekema, D.J. Epidemiology of invasive candidiasis: A persistent public health problem. Clin. Microbiol. Rev. 2007, 20, 133-163.26.
26. Caira, M.; Girmenia, C.; Fadda, R.M.; Mitra, M.E.; Picardi, M.; van Lint, M.T.; Nosari, A.; Candoni, A.; Bonini, A.; Mattei, D, et al. Invasive fungal infections in patients with acute myeloid leukemia and in those submitted to allogeneic hemopoietic stem cell transplant: Who is at highest risk? Eur. J. Haematol. 2008, 81, 242-243.
27. Pagano, L.; Caira, M.; Candoni, A.; Offidani, M.; Martino, B.; Specchia, G.; Pastore, D.; Stanzani, M.; Cattaneo, C.; Fanci, R, et al. Invasive aspergillosis in patients with acute myeloid leukemia: A SEIFEM-2008 registry study. Haematologica 2010, 95, 644-650.
28. Moretti, B.; Larocca, A.; Napoli, C.; Martinelli, D.; Paolillo, L.; Cassano, M.; Notarnicola, A.; Moretti, L.; Pesce, V. Active warming systems to maintain perioperative normothermia in hip replacement surgery: A therapeutic aid or a vector of infection? J. Hosp. Infect. 2009, 73, 58-63.
29. Alberti, C.; Bouakline, A.; Ribaud, P.; Lacroix, C.; Rousselot, P.; Leblanc, T.; Derouin, F. Relationship between environmental fungal contamination and the incidence of invasive aspergillosis in haematology patients. J. Hosp. Infect. 2001, 48, 198-206.
30. Crimi, P.; Valgiusti, M.; Macrina, G.; Grieco, A.; Massone, L.; Ciucci, A.; Ansaldi, F.; Sticchi, L.; Sasso, L.; del Buono, S.; Durando, P. Evaluation of microbial contamination of air in two haematology departments equipped with ventilation systems with different filtration devices. J. Prev. Med. Hyg. 2009, 50, 33-36.
31. Cornet, M.; Fleury, L.; Maslo, C.; Bernard, J.F.; Brücker, G.; Invasive Aspergillosis Surveillance Network of the Assistance Publique-Hôpitaux de Paris. Epidemiology of invasive aspergillosis in France: A six-year multicentric survey in the Greater Paris area. J. Hosp. Infect. 2002, 51, 288-296.
32. Marr, K.A.; Carter, R.A.; Crippa, F.; Wald, A.; Corey, L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 2002, 34, 909-917.
33. Castagnola, E.; Caviglia, I.; Pistorio, A.; Fioredda, F.; Micalizzi, C.; Viscoli, C.; Haupt, R. Bloodstream infections and invasive mycoses in children undergoing acute leukaemia treatment: A 13-year experience at a single Italian institution. Eur. J. Cancer 2005, 41, 1439-1445.
34. Zaoutis, T.E.; Heydon, K.; Chu, J.H.; Walsh, T.J.; Steinbach, W.J. Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the united states, 2000. Pediatrics 2006, 117, 711-716.
35. Kaya, Z.; Gursel, T.; Kocak, U.; Aral, Y.Z.; Kalkanci, A.; Albayrak, M. Invasive fungal infections in pediatric leukemia patients receiving fluconazole prophylaxis. Pediatr. Blood. Cancer 2009, 52, 470-475.